Skip to main content
UniHealth

Doctor search

Alison M Superko, NP

Physician Assistant · Mountain View

NPI 1699841767

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
2

Offices

2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Alison M Superko’s office to ask if they take your plan before you enroll.

Original Medicare doctor bills

$20,888

Medicare paid this office $20,888 for 255 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the30$10,681$73
Anticoagulant management of patient taking warfarin227$6,409$8
Return visit (30+ min)14$1,514$101
Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent31$1,032$7

Who their Medicare patients are

255 Original Medicare patients in 2024. Average age 81 · 85 and older 36% · Women 36% · Also on Medicaid 10% · Health risk score 1.54. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 75% · Atrial fibrillation 75% · Coronary heart disease 38% · Heart failure 38% · Chronic kidney disease 34% · Diabetes 29% · Cancer 15% · Dementia 11% · Stroke 11% · COPD 10% · Depression 10%.

The office billed $96,440, Medicare allowed $27,191 and paid $20,888; for 1,094 services of 9 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20242551,094811.54$96,440$20,888
2023117163811.81$9,462$2,163
20222051,472811.55$102,242$18,860
20212101,834811.45$171,313$46,912
20201841,611801.74$143,944$36,210
20192051,840811.82$165,118$39,530
20182432,406801.85$204,589$49,796
20173172,565801.72$200,288$48,876
20163112,433801.56$191,169$48,364
20152992,403801.58$191,821$46,574
20143072,887801.61$231,765$58,862
20132582,819801.59$224,594$58,894

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 2 services

Original Medicare services billed in 2023
Anticoagulant management of patient taking warfarin90$952$9
Blood test, clotting time37$164$4

2022: 5 services

Original Medicare services billed in 2022
Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the31$8,279$47
Blood test, clotting time173$3,210$4
Short return visit (20+ min)31$3,068$55
Anticoagulant management of patient taking warfarin119$2,256$8
Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent38$1,136$6

2021: 4 services

Original Medicare services billed in 2021
Short return visit (20+ min)147$29,809$70
Blood test, clotting time186$4,612$4
Short return visit58$3,705$43
Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent27$759$6

2020: 7 services

Original Medicare services billed in 2020
Short return visit (20+ min)118$19,865$57
Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the12$5,246$61
Blood test, clotting time163$3,974$4
Short return visit50$2,209$33
Influenza vaccine split virus, preservative free26$1,585$61
Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent12$675$7
Administration of influenza virus vaccine27$565$21

2019: 5 services

Original Medicare services billed in 2019
Short return visit (20+ min)129$23,486$55
Blood test, clotting time188$4,815$4
Short return visit70$3,978$35
Return visit (30+ min)14$1,158$83
Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent14$582$7

2018: 5 services

Original Medicare services billed in 2018
Short return visit (20+ min)174$30,955$53
Blood test, clotting time222$6,593$5
Short return visit73$3,271$31
Return visit (30+ min)19$1,474$78
Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent29$493$7

2017: 5 services

Original Medicare services billed in 2017
Short return visit (20+ min)202$33,480$53
Blood test, clotting time270$8,728$5
Short return visit100$4,447$31
Return visit (30+ min)17$1,464$86
Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent57$740$6

2016: 5 services

Original Medicare services billed in 2016
Short return visit (20+ min)199$32,568$56
Blood test, clotting time260$8,258$5
Short return visit95$4,492$32
Return visit (30+ min)22$1,797$82
Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent53$689$7

2015: 5 services

Original Medicare services billed in 2015
Short return visit (20+ min)200$30,215$53
Blood test, clotting time281$8,410$5
Short return visit112$5,900$33
New patient visit (30+ min)12$944$79
Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent17$141$7

2014: 5 services

Original Medicare services billed in 2014
Short return visit (20+ min)227$36,094$53
Short return visit166$11,104$33
Blood test, clotting time289$9,573$5
New patient visit (30+ min)21$1,728$82
Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent19$133$7

2013: 4 services

Original Medicare services billed in 2013
Short return visit (20+ min)196$29,281$54
Short return visit190$18,088$33
Blood test, clotting time257$9,006$5
New patient visit (30+ min)27$2,315$86

Drugs they prescribed that Part D paid

$3,465

Pharmacies billed $3,465 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 136) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.

136 generic and 0 brand-name prescriptions · $3,465 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Enoxaparin11$1,927$175
Warfarin122$1,515$12

Year by year

Part D prescribing by year
2024136530% (0)0%$3,465
2023189740% (0)0%$5,486
20223511180% (0)None$12,032
20212511060% (0)8%$13,897
2020233770% (0)9%$14,714
2019216790% (0)None$9,040
2018316920% (0)None$11,057
2017295920% (0)None$9,593
2016220860% (0)None$7,427
2015262810% (0)None$9,462
2014332940% (0)None$12,283
2013253760% (0)None$10,376

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 2 drugs

Part D drugs prescribed in 2023
Warfarin173$4,946$29
Jantoven15$277$18

2022: 3 drugs

Part D drugs prescribed in 2022
Warfarin318$7,252$23
Enoxaparin12$2,760$230
Jantoven20$322$16

2021: 3 drugs

Part D drugs prescribed in 2021
Warfarin212$5,082$24
Enoxaparin13$2,109$162
Jantoven14$378$27

2020: 2 drugs

Part D drugs prescribed in 2020
Warfarin199$6,087$31
Enoxaparin13$2,189$168

2019: 1 drug

Part D drugs prescribed in 2019
Warfarin196$5,334$27

2018: 2 drugs

Part D drugs prescribed in 2018
Warfarin291$8,068$28
Jantoven12$321$27

2017: 3 drugs

Part D drugs prescribed in 2017
Warfarin269$6,877$26
Enoxaparin11$2,013$183
Jantoven14$701$50

2016: 2 drugs

Part D drugs prescribed in 2016
Warfarin198$4,126$21
Enoxaparin11$2,762$251

2015: 1 drug

Part D drugs prescribed in 2015
Warfarin246$5,610$23

2014: 1 drug

Part D drugs prescribed in 2014
Warfarin310$5,997$19

2013: 1 drug

Part D drugs prescribed in 2013
Warfarin228$4,157$18

Money from drug and device companies

$329 in 2024

Industry payments by year
202433None$329
202311None$88
202211None$128
202111None$62

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Otsuka Pharmaceutical Development & CommercializationNone$122
1 payment
  • Meals · 2024-11-14 · $122
Gilead SciencesNone$121
1 payment
  • Meals · 2024-05-21 · $121
Boehringer Ingelheim PharmaceuticalsJardiance$87
1 payment
  • Meals for Jardiance · 2024-03-21 · $87
See all 3 published payments
Every published payment
Otsuka Pharmaceutical Development & CommercializationMeals · 2024-11-14None$122
Gilead SciencesMeals · 2024-05-21None$121
Boehringer Ingelheim PharmaceuticalsMeals · 2024-03-21Jardiance$87
See earlier years (2023, 2022, 2021)

2023: $88

Payments by company in 2023
Intercept PharmaceuticalsOcaliva$88
1 payment
  • Meals for Ocaliva · 2023-08-24 · $88

2022: $128

Payments by company in 2022
Vertos MedicalMild Device Kit$128
1 payment
  • Meals for Mild Device Kit · 2022-02-16 · $128

2021: $62

Payments by company in 2021
ColoplastRestorelle$62
1 payment
  • Meals for Restorelle · 2021-09-21 · $62

Professional record

NPI
1699841767
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Physician assistant (363A00000X)
Mailing address
2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
NPI first listed
2006-11-28
NPI last updated
2015-12-18

This is when the NPI record was last certified, not a medical board exam.